IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#434
Positioning
Market Dominance
Services
Healthcare
$2.1B
Jason Murray
We are a leading post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities. PACS Group, Inc. and its subsidiaries that are not licensed healthcare providers do not provide healthcare services to patients, residents or any other person, and do not direct or control the provision of services provided. All healthcare services are provided solely by applicable subsidiaries that are licensed healthcare providers, under the direction and control of licensed healthcare professionals in accordance with applicable law. Our principal executive offices are located at 262 N. University Ave, Farmington, Utah.
Headcount
—
HQ Base
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = PACS ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$PACS PACS Group, Inc. | 63 | 56 | 67 | 95 | 41.0x | 25.5x | 16.9% | 2.6% | 17.2% | 4.6% | 2.9% | 43.7% | 0.0% | 542.0x | $2.1B | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
PACS Group, Inc. (PACS) receives a "Hold" rating with a composite score of 62.9/100. It ranks #434 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Jason Murray
Chief Executive Officer
56
24
49
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for PACS
FARMINGTON, Utah
Outperforming peers — winners tend to keep winning over 3-12 months
Trading at a discount to fundamentals — favorable entry valuation
Average quality profile
Average volatility — neutral timing signal
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for PACS.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 56 | 69 | -13DRAG |
| MOMENTUM | 95 | 99 | -4NEUTRAL |
| VALUATION | 67 | 76 | -9DRAG |
| INVESTMENT | 24 | 10 | +14ALPHA |
| STABILITY | 49 | 49 | 0NEUTRAL |
| SHORT INT | 59 | 75 | -16DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 16.9% (sector 5.3%)
GM 17% vs sector 60%, OM 5% vs sector 4%
Capital turnover N/A
Rev growth 44%, 2yr history
Interest coverage 10.1x, Net debt/EBITDA -0.0x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns PACS Group, Inc. a Hold rating, with a composite score of 62.9/100 and 3 out of 5 stars. Ranked #434 of 7,333 stocks, PACS presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 56/100, PACS shows adequate but unremarkable business quality. The company reports a return on equity of 16.9% (sector avg: 5.3%), gross margins of 17.2% (sector avg: 59.6%), net margins of 2.9% (sector avg: 2.3%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
PACS's value score of 67/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 40.96x, an EV/EBITDA of 25.47x, a P/B ratio of 6.91x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
PACS Group, Inc.'s investment score of 24/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 43.7% vs. a sector average of 7.8% and a return on assets of 2.6% (sector: 1.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
PACS Group, Inc. (PACS) is exhibiting exceptional momentum with a score of 95/100, placing it among the strongest trending stocks in the market. Revenue growth stands at 43.7% year-over-year, while a beta of 0.66 reflects its sensitivity to broader market moves. Stocks with momentum scores this high have historically outperformed over the following 3–12 months, suggesting PACS may continue to benefit from strong institutional interest and positive price trends.
With a stability score of 49/100, PACS exhibits average financial resilience. Key stability metrics include a beta of 0.66 and a debt-to-equity ratio of 542.00x (sector avg: 0.3x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
The short interest score of 59/100 for PACS suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 542.00x). With a $2.1B market cap (mid-cap), PACS Group, Inc. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
PACS Group, Inc. is a mid-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #434 of 7,333 overall (94th percentile). Key comparisons include ROE of 16.9% exceeding the 5.3% sector median and operating margins of 4.6% above the 3.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While PACS currently exhibits a HOLD profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Key factor gap
Momentum (95) vs Investment (24) — closing this gap could shift the rating.
EV/EBITDA 117% ABOVE SECTOR MEDIAN
ROE 218% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 71% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate PACS Group, Inc. (PACS) as a Hold with a composite score of 62.9/100 at a current price of $39.65. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in momentum (95th percentile) and value (67th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (24th percentile) and stability (49th percentile) tempers our overall conviction. We assign a Narrow Moat rating (45/100), High uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress; sustainability of the current growth rate. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
PACS Group, Inc. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 62.9/100 places it at rank #434 in our full 7,333-stock universe. At $2.1B in market capitalization, PACS Group, Inc. is a mid-cap player in the Services space, which limits certain scale advantages but may allow for more agile strategic execution.
The near-term outlook is constructive, with revenue growing at 44% and momentum in the 95th percentile confirming positive market sentiment and institutional accumulation. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy. Investment factor at the 24th percentile indicates reinvestment patterns that investors should monitor for sustainability.
The margin cascade tells an important story: gross margins of 17% (-42.4pp vs sector) narrow to operating margins of 5% (+1.1pp vs sector) and net margins of 2.9%, yielding a gross-to-net conversion rate of 17%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $39.65, PACS Group, Inc. is trading near fair value based on current fundamentals. Our value factor score of 67/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 41.0x (a 73% premium to the sector median of 23.7x), EV/EBITDA of 25.5x (at a premium), P/B of 6.9x, P/S of 1.2x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis finds only partially justified by current fundamentals.
Returns on equity of 16.9% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
Revenue growth of 44% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
A value factor score of 67/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Positive momentum (95th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
A P/E of 41.0x leaves little room for execution misses — any earnings disappointment could trigger a sharp multiple compression.
We assign a High uncertainty rating to PACS Group, Inc.. Key risk factors include significant leverage (542% debt-to-equity), low beta of 0.66 — while defensive, this may indicate limited upside participation in bull markets, elevated valuation multiple (P/E 41.0x) that leaves limited margin for error. The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: significant leverage (542% debt-to-equity); low beta of 0.66 — while defensive, this may indicate limited upside participation in bull markets; elevated valuation multiple (P/E 41.0x) that leaves limited margin for error; the combination of leverage (542% D/E) and thin margins (2.9% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 49th percentile and quality factor at the 56th percentile provide a quantitative summary of the overall risk landscape.
We identify limited risk mitigants at this time, which contributes to our high uncertainty assessment. Investors should monitor for improvement in balance sheet metrics, margin stability, and business predictability that could warrant a downgrade in our risk assessment over time.
We rate PACS Group, Inc.'s capital allocation as Poor. Key concerns include elevated leverage (542% D/E). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — PACS Group, Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, PACS Group, Inc. receives a Hold rating with a composite score of 62.9/100 (rank #434 of 7,333). Our quantitative framework assigns a Narrow Moat (45/100, trend: stable), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 58/100.
Our analysis supports a neutral stance on PACS Group, Inc.. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign PACS Group, Inc. a Narrow Moat rating with a composite moat score of 45/100. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that PACS Group, Inc. can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being financial resilience at 17.5/20.
The strongest moat sources are financial resilience (17.5/20) and growth durability (11.4/20). Interest coverage 10.1x, Net debt/EBITDA -0.0x. Rev growth 44%, 2yr history. These pillars form the core of PACS Group, Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and margin superiority (6.5/20). Capital turnover N/A. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect PACS Group, Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include robust top-line growth of 44% expanding the revenue base, returns on equity of 16.9% driving shareholder value creation. The margin cascade from 17% gross to 5% operating to 2.9% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 56th percentile.
The margin profile shows gross margins of 17%, operating margins of 5%, net margins of 2.9%. Return metrics include ROE of 16.9% and ROA of 2.6%. Relative to the Services sector, gross margins are 42.4 percentage points below the sector median of 60%, and ROE of 16.9% compares to a sector median of 5.3%.
The balance sheet reflects high leverage with D/E of 542%, which may limit financial flexibility, revenue growth of 44%. The sector median D/E is 0%, putting PACS Group, Inc. at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Elevated leverage (542% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of 2.9% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Above 50MA
37.18%
Net New Highs
+51081
PACS Group recently expanded its footprint by acquiring the operations of three post-acute care facilities in Alaska and Idaho, totaling 230 beds, while also purchasing the real estate for facilities in Alaska, California, and Arizona and leasing one Idaho site. This mix of owned and leased properties highlights how PACS Group is tailoring its asset base to support high-acuity care growth in targeted regional markets. With this latest round of facility and real estate acquisitions, we will...
SALT LAKE CITY, January 20, 2026--PACS Group, Inc. (NYSE: PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds.

Evelyn Dilsaver, a PACS Group director, purchased 16,724 shares worth $500,000 on November 24, 2025, increasing her direct ownership by 278%. The purchase suggests confidence in the company's strong financial performance and growth potential.
Latest Best in KLAS recognition reflects continued client trust and product excellence.Basingstoke, England, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Intelerad, a global leader in medical imaging software solutions, has been named a 2026 Best in KLAS award winner for its InSight PACS solution in the UK and Ireland for the third straight year. The ranking is determined by direct feedback from healthcare users and providers in 2025. Tailor-made to support both the complex needs of the NHS and the countri
PACS Group recently expanded its post-acute care footprint by acquiring the operations of three facilities in Alaska and Idaho, adding 230 beds and purchasing the underlying real estate for several of these properties, while leasing one from a third-party landlord. This mix of owned and leased assets offers insight into how PACS Group balances capital deployment with operational flexibility as it grows its skilled nursing and assisted living platform. Next, we’ll examine how this latest...